Medifast, Inc. (MED) return on equity (ROE)

Return on equity · fiscal 2025
-9.4%

Medifast, Inc. (MED) earned a return on equity of -9.4% in fiscal 2025 (the year ended December 31, 2025). That is 10.4 percentage points lower than the 1.0% of fiscal 2024. Figures as of 19 Nov 2026, 14:20 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2025
-9.4%
Change on fiscal 2024
−10.4 pts
Highest on record
92.6%fiscal 2022
Lowest on record
-9.4%fiscal 2025
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Medifast, Inc. return on equity (ROE), in more detail

Across the 17 fiscal years on record (2009–2025), the highest was 92.6% in fiscal 2022 and the lowest -9.4% in fiscal 2025. The fiscal 2025 figure is no higher than in any of the 16 earlier fiscal years on record, whose median is 25.6%.

History · 17 fiscal years

Return on equity by fiscal year

Medifast, Inc. return on equity (ROE), year by year

Medifast, Inc. (MED) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
2025-9.4% 10.4 pts down
20241.0% 48.3 pts down
202349.3% 43.3 pts down
202292.6% 11.6 pts up
202181.0% 15.6 pts up
202065.4% 8.9 pts down
201974.3% 23.2 pts up
201851.1% 25.1 pts up
201726.0% 7.4 pts up
201618.6% 4.1 pts down
201522.6% 6.3 pts up
201416.4% 8.0 pts down
201324.4% 6.9 pts up
201217.5% 7.8 pts down
201125.3% 2.0 pts down
201027.3% 3.5 pts up
200923.8%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

More on MED

Medifast, Inc., figure by figure

Medifast, Inc. (MED) overview: price, valuation and scorecard

Medifast, Inc. return on equity (ROE): questions and answers

What is Medifast, Inc.'s return on equity?

Medifast, Inc. (MED) earned a return on equity of -9.4% in fiscal 2025 (the year ended December 31, 2025). That is 10.4 percentage points lower than the 1.0% of fiscal 2024.

Is Medifast, Inc.'s return on equity high or low compared with its own history?

The fiscal 2025 figure is no higher than in any of the 16 earlier fiscal years on record, whose median is 25.6%.

What are the highest and lowest return on equity figures on record for Medifast, Inc.?

Across the 17 fiscal years on record (2009–2025), the highest was 92.6% in fiscal 2022 and the lowest -9.4% in fiscal 2025.

How is Medifast, Inc.'s return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative. For Medifast, Inc. it is on record here for 17 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Medifast, Inc. (MED) return on equity (ROE)”, data as of 19 November 2026. https://funkfolio.com/stock/MED/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.